Warning Letter — vapetrinity.com
The FDA Center for Tobacco Products issued a warning letter to vapetrinity.com on May 19, 2026, regarding regulatory compliance issues. The source indicates this action stems from an inspection or review of the company's online marketing activities.
This affects vapetrinity.com, online retailers of tobacco products, and regulatory compliance teams responsible for electronic nicotine delivery systems (ENDS).
This enforcement action indicates continued FDA oversight of online retail platforms under the Center for Tobacco Products' jurisdiction. Regulatory professionals should interpret this as a signal that the FDA is actively monitoring digital sales channels for compliance with marketing requirements; failure to address such letters typically leads to further civil money penalties or permanent injunctions.
Retailers and online platforms must conduct an immediate review of their product listings to ensure every electronic nicotine delivery system (ENDS) product has an active marketing authorization from the FDA. Marketing and regulatory teams should evaluate internal audit procedures for verifying the legal status of products sold via e-commerce platforms.
FDA Warning Letter issued to: vapetrinity.com. 05/19/2026 — Center for Tobacco Products. Source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/vapetrinitycom-730109-05192026
Open in openFDA / FDA.gov